title: Effects of brassinazole, an inhibitor of brassinosteroid biosynthesis, on light- and dark-grown Chlorella vulgaris.
abstract: Treatment of cultured Chlorella vulgaris Beijerinck cells with 0.1-10 microM brassinazole (Brz2001), an inhibitor of brassinosteroid (BR) biosynthesis, inhibits their growth during the first 48 h of cultivation in the light. This inhibition is prevented by the co-application of BR. This result suggests that the presence of endogenous BRs during the initial steps of the C. vulgaris cell cycle is indispensable for their normal growth in the light. In darkness, a treatment with 10 nM brassinolide (BL) promotes growth through the first 24 h of culture, but during the following 24 h the cells undergo complete stagnation. Treatment of dark-grown cells with either Brz2001 alone, or a mixture of 10 nM BL and 0.1/10 microM Brz2001, also stimulates their growth. The effects of treatment with 10 nM BL mixed with 0.1-10 microM of a mevalonate-pathway inhibitor (mevinolin), or a non-mevalonate-pathway inhibitor (clomazone), were also investigated. Mevinolin at these concentrations did not inhibit growth of C. vulgaris; however, clomazone did. Addition of BL overcame the inhibition. These results suggest that the mevalonate pathway does not function in C. vulgaris, and that the non-mevalonate pathway for isopentenyl diphosphate biosynthesis is responsible for the synthesis of one of the primary precursors in BR biosynthesis.
authors.affiliation: Institute of Biology, University of Bialystok, Swierkowa 20 B, 15-950, Bialystok, Poland. abajguz@uwb.edu.pl
authors.forename: Andrzej
authors.initials: A
authors.lastname: Bajguz
authors.forename: Tadao
authors.initials: T
authors.lastname: Asami
mesh_terms: D060406:Brassinosteroids; D002708:Chlorella / Q000187:drug effects* / Q000254:growth & development / Q000528:radiation effects; D002777:Cholestanols / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D003624:Darkness; D045782:Hemiterpenes / Q000096:biosynthesis*; D007555:Isoxazoles / Q000494:pharmacology; D008027:Light; D008148:Lovastatin / Q000494:pharmacology; D009943:Organophosphorus Compounds; D023303:Oxazolidinones / Q000494:pharmacology; D013260:Steroids, Heterocyclic / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D014230:Triazoles / Q000494:pharmacology*
chemical_list: D060406:Brassinosteroids; C451122:Brz2001; D002777:Cholestanols; D045782:Hemiterpenes; D007555:Isoxazoles; D009943:Organophosphorus Compounds; D023303:Oxazolidinones; D013260:Steroids, Heterocyclic; D014230:Triazoles; C004809:isopentenyl pyrophosphate; C095255:clomazone; D008148:Lovastatin; C412342:brassinazole; C023623:brassinolide